Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 2
2011 1
2012 3
2013 5
2015 2
2016 5
2017 2
2018 6
2019 2
2020 4
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Results by year
Filters applied: . Clear all
Page 1
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.
Nassar ZD, Mah CY, Dehairs J, Burvenich IJ, Irani S, Centenera MM, Helm M, Shrestha RK, Moldovan M, Don AS, Holst J, Scott AM, Horvath LG, Lynn DJ, Selth LA, Hoy AJ, Swinnen JV, Butler LM. Nassar ZD, et al. Among authors: centenera mm. Elife. 2020 Jul 20;9:e54166. doi: 10.7554/eLife.54166. Elife. 2020. PMID: 32686647 Free PMC article.
A patient-derived explant (PDE) model of hormone-dependent cancer.
Centenera MM, Hickey TE, Jindal S, Ryan NK, Ravindranathan P, Mohammed H, Robinson JL, Schiewer MJ, Ma S, Kapur P, Sutherland PD, Hoffmann CE, Roehrborn CG, Gomella LG, Carroll JS, Birrell SN, Knudsen KE, Raj GV, Butler LM, Tilley WD. Centenera MM, et al. Mol Oncol. 2018 Sep;12(9):1608-1622. doi: 10.1002/1878-0261.12354. Epub 2018 Aug 16. Mol Oncol. 2018. PMID: 30117261 Free PMC article.
Dual roles of PARP-1 promote cancer growth and progression.
Schiewer MJ, Goodwin JF, Han S, Brenner JC, Augello MA, Dean JL, Liu F, Planck JL, Ravindranathan P, Chinnaiyan AM, McCue P, Gomella LG, Raj GV, Dicker AP, Brody JR, Pascal JM, Centenera MM, Butler LM, Tilley WD, Feng FY, Knudsen KE. Schiewer MJ, et al. Among authors: centenera mm. Cancer Discov. 2012 Dec;2(12):1134-49. doi: 10.1158/2159-8290.CD-12-0120. Epub 2012 Sep 19. Cancer Discov. 2012. PMID: 22993403 Free PMC article.
Extracellular Fatty Acids Are the Major Contributor to Lipid Synthesis in Prostate Cancer.
Balaban S, Nassar ZD, Zhang AY, Hosseini-Beheshti E, Centenera MM, Schreuder M, Lin HM, Aishah A, Varney B, Liu-Fu F, Lee LS, Nagarajan SR, Shearer RF, Hardie RA, Raftopulos NL, Kakani MS, Saunders DN, Holst J, Horvath LG, Butler LM, Hoy AJ. Balaban S, et al. Among authors: centenera mm. Mol Cancer Res. 2019 Apr;17(4):949-962. doi: 10.1158/1541-7786.MCR-18-0347. Epub 2019 Jan 15. Mol Cancer Res. 2019. PMID: 30647103 Free article.
Maximizing the Therapeutic Potential of HSP90 Inhibitors.
Butler LM, Ferraldeschi R, Armstrong HK, Centenera MM, Workman P. Butler LM, et al. Among authors: centenera mm. Mol Cancer Res. 2015 Nov;13(11):1445-51. doi: 10.1158/1541-7786.MCR-15-0234. Epub 2015 Jul 28. Mol Cancer Res. 2015. PMID: 26219697 Free PMC article. Review.
Hsp90: still a viable target in prostate cancer.
Centenera MM, Fitzpatrick AK, Tilley WD, Butler LM. Centenera MM, et al. Biochim Biophys Acta. 2013 Apr;1835(2):211-8. doi: 10.1016/j.bbcan.2012.12.005. Epub 2012 Dec 31. Biochim Biophys Acta. 2013. PMID: 23287571 Review.
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page